Current Projects

Project 195 – Description of the plasma proteome in advanced kidney disease: a pilot study

06 Jan 2020

Dr Rajesh Raj – $17,281 Proteins are found everywhere in the human body – in all body tissues and most bodily fluids. Because of their ubiquitous nature, these proteins are likely to be altered by the metabolites that accumulate in conditions such as chronic kidney disease. Under normal circumstances, the quantities of some of the

Project 194 – Multidisciplinary approach to antenatal care to improve the health of pregnant women and their offspring: Healthy outcomes for the future (HOFF) program

Mrs Sharon Luccisano  – $62,607 Maternal obesity and gaining weight above recommendations, can result in adverse outcomes for both women and their babies including – gestational diabetes (GDM), pre-eclampsia, premature birth, macrosomia (large babies), postpartum haemorrhage and neonatal death. A recent audit estimates 54.6% of pregnant women presented at antenatal clinics in the NW were

Project 193 – Trial of Exenatide in Acute Ischaemic Stroke (TEXAIS)

Dr Matt Lee – Archer $57,031.92 Stroke is one of Australia’s biggest killers and a leading cause of disability. Stroke kills more women than breast cancer and more men than prostate cancer. In 2017 there were more than 56,000 new and recurrent strokes – that is one stroke every nine minutes.

Project 192 – Enhancement and further in-vitro validation of a potential probiotic to reduce ear and lung infections caused by Haemophilus influenzae

Dr Stephen Tristram – $19,965 The bacterium Haemophilus influenzae commonly colonises the upper airways of healthy people yet under certain predisposing conditions, it is also causes various lower respiratory tract and ear infections. These infections cause significant disease in individuals, frequently become chronic, are a major burden on the healthcare system and are difficult to

Project 191 – N/NW TAS: Establishment of a Tasmanian lung cancer registry: a north and north-west collaborative initiative

Dr Sukhwinder Sohal – $80,000 Lung cancer is one of the most common forms of cancer in the world, with 1.8 million new cases detected annually (as of 2015) and 1.6 million deaths worldwide. The current average survival rate for patients with lung cancer varies from 4–18.6% depending on regional differences; the variation in outcomes